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Human FOXP3þCD25þCD4þ regulatory Tcells (Tregs) are essential to the maintenance of immune
homeostasis. Several genes are known to be important for murine Tregs, but for human Tregs the
genes and underlying molecular networks controlling the suppressor function still largely remain
unclear. Here, we describe a strategy to identify the key genes directly from an undirected
correlation network which we reconstruct from a very high time-resolution (HTR) transcriptome
during the activation of human Tregs/CD4þ T-effector cells. We show that a predicted top-ranked
new key gene PLAU (the plasminogen activator urokinase) is important for the suppressor function
of both human and murine Tregs. Further analysis unveils that PLAU is particularly important for
memory Tregs and that PLAU mediates Treg suppressor function via STAT5 and ERK signaling
pathways. Our study demonstrates the potential for identifying novel key genes for complex
dynamic biological processes using a network strategy based on HTR data, and reveals a critical role
for PLAU in Treg suppressor function.
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Introduction
Autoimmune diseases are currently ranked as the third most
important disease category in the United States, following
heart disease and cancer. Autoimmunity plays a crucial role in
480 human diseases. A subpopulation of T cells, called
regulatory T cells, currently recognized as FOXP3þCD25þ
CD4þ regulatory T cells (Tregs), are pivotal in suppressing
autoimmunity and maintaining immune homeostasis
(Sakaguchi, 2004; Ochs et al, 2005; Bacchetta et al, 2007;
Germain, 2008). Furthermore, Tregs suppress immune
responses against allergens (Chatila, 2005), tumor cells
(Knutson et al, 2007), infections (Belkaid, 2007), potentially
neurodegenerative diseases (He and Balling, 2012), and other
diseases (Bacchetta et al, 2007). The suppressive activity of
Tregs can be beneficial or detrimental to the host. Defects in
Tregs may lead to the development of autoimmunity or the
failure to control the intensity of effector responses, whereas
overreactive Tregs may contribute to tumor progression.
Therefore, it is essential to reveal the underlying molecular
mechanisms involved in Treg function.
A number of human and/or murine genes, such as FOXP3,
NFAT, EOS, S1PR1, GAL1, GAL10, FGL2, and RUNX1 are
important for the suppressive function and anergy of Tregs
(Fontenot et al, 2003; Sakaguchi, 2005; Wu et al, 2006; Ziegler,
2006; Garin et al, 2007; Kubach et al, 2007; Ono et al, 2007;
Shalev et al, 2008; Josefowicz and Rudensky, 2009; Liu et al,
2009; Pan et al, 2009; Shevach, 2009; Sakaguchi et al, 2010).
Foxp3 for example has been described as a master regulator of
murine Treg function and development, and a number of target
genes of this transcriptional regulator have been identified by
chromatin-immunoprecipitation analysis (Marson et al, 2007;
Zheng et al, 2007). Although significant advances have been
made in understanding murine Treg lineage commitment and
function gained mainly by studying Foxp3, the dominant role
of FOXP3 in human Treg cells might need to be reconsidered
(Probst-Kepper et al, 2010). Differences in the role of this so-
called master regulator between human and murine Tregs
might indicate additional differences in the molecular net-
works controlling the suppressor function of human and
murine Tregs. Recently, we and others have shown that GARP
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(LRRC32) is important for the suppressor function and the
regulation of FOXP3 expression in human Tregs (Probst-
Kepper et al, 2009; Wang et al, 2009). However, little has been
done to systematically identify other genes involved and the
underlying gene networks that control human Treg function.
This is partially due to the lack of sufficient high-quality
genome-wide dynamic data and the lack of a suitable strategy
by which one can construct reliable gene networks and
identify the key genes that regulate human Treg function (He
et al, 2009).
The inference of mechanistic transcription regulatory net-
works in mammalian cells is an important basis to obtain
insight into biological and disease processes. However,
conclusions about their accuracy and the experimental
validation of potential interactions that have been computa-
tionally generated are still very challenging (Walhout, 2011;
Della Gatta et al, 2012; Quo et al, 2012; Stelniec-Klotz et al,
2012). Determination of multivariate dependencies of target
genes, that are under the synergistic control of multiple
regulators, is even more difficult and can often only be solved
by approximation methods (Huynh-Thu et al, 2010; Quo et al,
2012) such as maximum entropy techniques (Margolin et al,
2010). Additional difficulties arise in validating these multi-
regulator-synergistic regulatory networks. Inferring gene
association networks by taking into account multivariate
stochastic dependencies among genes, for instance using
partial correlation from static measurements is possible (also
known as covariance selection) (Toh and Horimoto, 2002;
de la Fuente et al, 2004; Schafer and Strimmer, 2005), which
however cannot easily transfer to the cases of dynamic data.
Some advanced approaches have been developed to identify
synergistically interacting genes based on multivariate depen-
dencies, which however form undirected correlation networks
that therefore cannot provide direct functional regulatory
evidence (Anastassiou, 2007). In the present work, we
describe a simplified pairwise correlation network that never-
theless allows the identification of important network
components.
Lee et al (2004) have proposed a strategy to obtain
correlation linkages and constructed gene–gene correlation
networks in yeast by combining different data sets under
diverse conditions. Other efforts have also been made to
identify correlation networks (Huttenhower et al, 2006;
Langfelder and Horvath, 2008; Ruan et al, 2010). The validity
of parts of such gene–gene correlation networks has been
successfully demonstrated in yeast and in human B cells by
small-scale experimental verification (Basso et al, 2005; Lee
et al, 2007). However, the results are primarily based on the
integration of static array data obtained under different
conditions and thus do not take into account the dynamics of
process-specific gene regulation. Furthermore, no studies
attempted to identify the genes critical for a given physiological
or pathological process obtained from the inferred undirected
correlation networks based on gene expression data.
Here, we used a combination of high time-resolution (HTR)
genome-wide gene expression analysis, systems-biology
reverse engineering and small-scale biochemical, genetic,
and cell-biological studies in addition to murine models to
construct a correlation network and identify key genes in
human Tregs during the early process of Treg activation.
Results
Generating HTR dynamic transcriptome
Based on the assumption that the key regulatory events
underlying Treg activation occur very early after activation, we
analyzed the dynamics of genome-wide gene expression in
Tregs and CD4þ Teffector cells (Teffs) during the first 6 h after
stimulation.
Stable Tregs derived from sorted human CD4þCD25high
T cells and alloantigen-specific Teffs derived from sorted
CD4þCD25 T cells were from the same batch of Tregs and
Teffs from our recent work (Probst-Kepper et al, 2009).
Whereas the long-term responses of these Tcells in the course
of days following activation have already been characterized
(Probst-Kepper et al, 2009), in the present study we employed
HTR gene expression analysis with a sampling time interval of
only 20min during the first 6 h post activation of anti-CD3/-
CD28/IL2 (Figure 1A). This enabled us to monitor the
dynamics of immediate response of transcriptional changes,
which cannot be captured by static and long time-interval
measurements (He et al, 2009).
Tregs are notable for their lack of effector cytokine
production in response to stimulation, as observed in long-
term stimulation experiments (Sakaguchi et al, 2006). We
found an almost undetectable low level of Th1 and Th2
cytokine gene expression (e.g., IL2, IL4, IL13, CSF2, and IFNG)
in unstimulated Tregs and Teffs. However, surprisingly it is
already within 1 h instead of days following stimulation that
these cytokines were significantly upregulated in Teffs but not
in Tregs (Figure 2A). An immediate-upregulation response
might be partially due to the fact that most of the Tregs and
Teffs become CD45ROþ memory T cells after several rounds
of exposure to irradiated allogeneic Epstein-Barr virus (EBV)-
transformed B cells (EBV-B cells) (Supplementary Figure S13a).
Nevertheless, the demonstration of a differential expression of
cytokines by Tregs and Teffs alreadywithin 1 h underscores the
importance of monitoring gene expression early after activa-
tion and the necessity of sampling at a high frequency. Within
6 h, 1667 genes showed significantly higher expression in
Tregs compared to Teffs, while 977 genes were expressed at
lower levels in Tregs (see Materials and methods and all the
related data are available on the webpage http://www.uni.lu/
lcsb/publications/databases_networks_tools).
The direct targets of murine Foxp3 have been reported to be
significantly enriched for genes involved in the T-cell receptor
signaling pathway found by chromatin immunoprecipitation-
chip analysis (Marson et al, 2007). In the current study, the
genes displaying a significant downregulation of expression
immediately after activation were significantly enriched in the
human T-cell receptor signaling pathway (Supplementary
Figure S1, cumulative binomial distribution test, P-value¼ 2.6
 10 6). This is the first direct evidence from time-course
expression results, which suggest that the human T-cell
receptor signaling pathway has been significantly down-
regulated immediately following activation. Although the
level of FOXP3 expression was much higher in Tregs versus
Teffs, the expression level of FOXP3 in Tregs was not
significantly changed over time after activation (Figure 2B).
The HTR expression data presented here provide evidence that
the role of FOXP3 in human Tregs might be overestimated and
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that other genes in addition to FOXP3 might play a key role in
human Treg function also as indicated in a recent computa-
tional study (Fu et al, 2012).
The overlap was very significant between differentially
expressed genes identified by us and those reported by other
Treg-expression studies, although it could be affected bymany
facts, such as stimulation duration differences and the
complexity of different Treg subpopulations (Feuerer et al,
2010). Approximately 57% of the genes reported by Lucas and
his colleagues to be upregulated in human Tregs after
stimulation for 1 day showed an overlap with the genes
identified by us (Stockis et al, 2009) (P-value¼ 6.110 6,
cumulative binomial distribution test, Supplementary
Table 1). Pfoertner et al (2006) have also reported upregulated
and downregulated gene sets in human Tregs. Approximately
53% of their reported upregulated genes also show signifi-
cantly higher expression in Tregs than in Teffs in our HTR data
(P-value¼ 1.310 9). Among the genes reported to be
downregulated by them, B45% of the genes were also
significantly downregulated in Tregs in our present work
(P-value¼ 2.810 6). In addition, Hill et al (2007) reported a
so-called reliable murine Treg signature. Being aware of the
differences between human and murine Tregs, B34% of the
genes in their murine Treg signature set are also differentially
expressed in human Tregs versus Teffs in the current study
(P-value¼ 5.910 3).
Constructing a Treg-specific correlation network
from HTR data
On the basis of the high-quality HTR time-series data, we
generated a probabilistic function-associated correlation
networks, specific for Tregs. For this purpose, we used
a combination of two methods, the Trend Correlation (TC)
(He and Zeng, 2006) method and the Local Clustering (LC)
(Qian et al, 2001) coefficient method. Both methods are able to
identify dynamic correlation linkages between pairs of genes
on the basis of time-series data by considering time shift and
positive/inverted correlation and are based on the assumption
that a robust correlation between the expression of genes over
time is highly linked to the degree of functional association
(Lee et al, 2004; He et al, 2009). By comparing the correlation
linkages obtained between Tregs and Teffs, we identified a
Figure 1 Strategy for identifying novel key genes for Treg suppressor function
by constructing a dynamic correlation network specific for Tregs. (A) The
sampling schedule for generating high time-resolution (HTR) time-series
transcriptomic data in Tregs/Teffs immediately following anti-CD28/-CD3/IL2
stimulation. (B) Construction of individual gene–gene correlation networks for
Tregs/Teffs and identification of the Treg-specific correlation linkages that only
exist in Tregs, but not in Teffs. (C) Construction of the Treg-specific correlation
network from Treg-specific correlation linkages. (D) We first extracted the
subnetwork for each given gene. The subnetwork consisted of all the genes with
a correlation linkage to the given gene. We then found the overlap between the
collection of literature-reported potential Treg-relevant genes and the genes with
a correlation linkage to the given gene in each subnetwork. The hub gene is the
purple one in the middle of each subnetwork. (E) In the left column, we inferred
the functional relevance (Pf) for each hub gene by using a cumulative binomial
distribution test based on the information obtained in (D). P is the overall
percentage of the collection of literature-reported potential Treg genes among all
the 9654 genes analyzed here. In the right column, we calculated the expression
difference (Pe) between Tregs and Teffs for each hub gene. (F) We integrated the
two values Pf and Pe by logarithm transforming them into a comparable range.
We then identified the testable key hub candidate genes based on the ranked
integrated value Ps. The sign Abs in the panel indicates the absolute value.
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Treg-specific correlation network. Using stringent P-value
criteria (refer to Materials and methods), we finally obtained
1 419 544 correlation linkages in the Treg-specific correlation
network. In contrast, random shuffling of our data from
different time points using the same methods only resulted in
identification of B4000 correlation linkages (Supplementary
Figure S2, a theoretical false positive rate of 210 3). First,
we checked the overall quality of the constructed Treg-specific
correlation network. Because two genes directly connected in
the constructed network are expected to share the same
Figure 2 Low expression of effector cytokines, high expression of CCL20, FOXP3, and GARP (LRRC32) in stimulated Tregs versus Teffs in the first 6 h and GARP
subnetwork. (A) The kinetics of transcriptional expression of chosen cytokines in the first 6 h assessed by HTR time-series data. Treg1 and Treg2 (or Teff1 and Teff2) are
the two independent repeated HTR time-series experiments for Tregs (or Teffs). Numbers on the x-axis indicate the corresponding sampling time points. Time point 1 is
the activation starting time zero and each interval is 20 min. (B) The kinetics of CCL20 (left), FOXP3 (middle), and GARP (right) expression in the first 6 h assessed by
HTR time-series data. (C) The GARP subnetwork extracted from the constructed Treg-specific correlation network based on the HTR transcription data by the proposed
strategy. Each oval represents one gene. Each line between GARP and the other genes represents a correlation linkage.
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biological process or similar function, we systematically
examined the co-occurrence of two genes in the annotated
same biological processes for each correlation linkage of the
entire constructed correlation network. We observed that
correlation linkages, in which two genes share an identical
biological process, were significantly enriched for 212 out
of the 860 annotated individual biological processes
(Supplementary Table 2). These significantly enriched path-
ways include regulation of immune responses, Tcell costimu-
lation, leukocyte migration, T-cell receptor signaling, and
the process involved in regulatory T-cell differentiation
(Supplementary Figure S3).
Second, to evaluate the quality of the constructed Treg-
specific correlation network, we examined the particular
subnetworks implicated in Treg function in more detail. One
of these subnetworks contains genes with a linkage to FOXP3,
a known master regulator of Tregs. When we compared the
genes identified in our study to a gene set composed of murine
Foxp3-binding genes (Marson et al, 2007), we observed a
significant enrichment by a cumulative binomial distribution
test (P-value¼ 8.910 4). A total of 18% of the genes
overlapping murine Foxp3-binding genes and genes known
to be involved in T-cell function were also linked to FOXP3 in
our network (P-value¼ 4.910 4). Importantly, the genes
surrounding FOXP3 were significantly enriched for human
genes known to be involved in autoimmune diseases (17%, P-
value¼ 2.710 6, Supplementary Table 3).
Third, we also checked the subnetwork of GARP, a gene
recently identified by our group and others to be important for
Treg function (Probst-Kepper et al, 2009; Wang et al, 2009;
Figure 2C). As shown by the HTR data (Figure 2B), GARP was
significantly upregulated immediately following activation of
Tregs but not in Teffs, indicating the importance of GARP for
Tregs. We identified 152 genes with a linkage to GARP
(Supplementary Table 4). A total of 59 out of these 152 genes
exhibited significantly differential expression in Tregs versus
Teffs (Supplementary Table 4). A total of 39 genes in the GARP
subnetwork overlapped with either murine Foxp3-binding
genes (Marson et al, 2007), Foxp3 target genes (as reported by
Marson et al, 2007), human autoimmune diseases-related
genes, the murine Treg signature gene set (Hill et al, 2007) or
the genes reported to be important for Treg function
(Supplementary Tables 4 and 5).
Because the identification of a linkage between two genes in
our correlation network might indicate either a transcriptional
relationship or other functional associations, we experimen-
tally tested whether the genes linked to GARP were also
dependent on GARP expression. For this purpose, we used
Teffs retrovirally overexpressing GARP as described (Probst-
Kepper et al, 2009). Here, we measured and compared the
expression of genes in GARP-overexpressing Teffs versus
empty vector-control GFP-expressing Teffs at three time points
(0, 100, and 360min, Supplementary Table 4). Notably, 97 out
of the 152 genes showed at least two-fold changes at no fewer
than two measured time points (P-value¼ 1.7107). We
found thatB43% of the 152 genes were changed at least two-
fold after stimulation at both 100 and 360min (P-value¼ 1.2
 107). Taken together, we provide three lines of evidence
confirming that the constructed Treg-specific correlation
network is biologically relevant.
Identifying PLAU as a key functional hub from
the constructed network
We were interested in using the constructed Treg-specific
correlation network as a hypothesis generator to come upwith
new testable ideas concerning the function of individual genes
or gene sets that might be relevant to Treg suppressor function.
Using this constructed Treg-specific correlation network, we
predicted and ranked key candidate genes.
Successfully extracting such information from large and
highly complex gene–gene networks is still very difficult. To
solve this problem, we developed a strategy to infer the
functional relevance of genes from constructed undirected
gene–gene networks by integrating information from subnet-
works, literature mining, and expression differences.
As a starting point, we performed text mining to assemble a
list of potential Treg-relevant genes to be used for predicting
the functional importance of genes in the constructed network.
We collected B400 genes mainly based on reported genomic
data as described in Supplementary Table 5.
We then compared these 400 genes with those directly
connected to the genes with more than a certain number of
linkages in the constructed network, with 10 used here
(Figure 1). Genes with 410 correlation linkages were called
hubs. If the genes directly connected to a given gene were
significantly enriched in the collection of 400 genes on the
basis of a cumulative binomial test, then we defined this gene
as a functional hub. Of note, we did not compare the 400 genes
with the hubs themselves, but we inferred the importance of
the hub genes according to the enrichment of the genes directly
connected to them. This is based on our hypothesis that the
higher the enrichment of literature-reported Treg genes
directly connected to a given gene, the higher the possibility
the given gene is a Treg-important gene. This method can be
imagined as if one searches for a queen bee, analogous to a
novel key gene, by specifically looking for those bees heavily
surrounded by other bees. We call this the queen bee-
surrounding principle (Figure 1).
To prioritize potential candidate hub genes for functional
validation studies, we ranked functional hubs by integrating
two values, which were the cumulative binomial test P-value
based on the identified probabilistic functional association
network indicating the potential functional importance of the
hubs (Pf) and the P-value representing the degree of expression
difference between Tregs and Teffs (Pe) (Figures 1E and F).
Using this strategy, we expect to identify other important genes
that cannot be discovered by only comparing the mRNA and/
or protein expression differences that are typically not big
enough to warrant further investigation.
Among the top 100 hub genes whose expression was
significantly upregulated in Tregs versus Teffs, 4 hubs are
known to be involved in human autoimmune diseases in
OMIM database (refer to Materials and methods and
Supplementary Table 6, cumulative binomial distribution,
P¼ 2.610 2). From the top 100 hub genes whose expression
was significantly downregulated (refer to Materials and
methods), 8 hubs were reported to be human autoimmune
disease-related genes (Supplementary Table 8, P¼ 4.610 5).
10 out of the top 100 downregulated hubs are murine
Foxp3-binding genes (Supplementary Table 7, P¼ 4.210 2).
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In contrast to the downregulated genes, the upregulated genes
were not significantly enriched for Foxp3-binding genes among
the top 100 hub genes (P¼ 0.74), which is consistent with the
report that murine Foxp3 mainly functions as a negative
transcriptional regulator (Marson et al, 2007).
Surprisingly, 6 out of the top 10 ranked upregulated hub
genes identified by our strategy are known to be involved in
Treg suppressor function or autoimmune diseases or disorders
(Table I). The top-ranked hub gene was GARP. GARP is a key
receptor for Treg suppressor function, and for the regulation of
FOXP3 expression in Tregs (Probst-Kepper et al, 2009; Wang
et al, 2009). The second and the seventh key hub genes
identified in our work were IL1R1 (CD121a) and IL1R2
(CD121b), respectively. IL1R1- and IL1R2-positive cells show
significantly higher suppressive capability than IL1R1- and
IL1R2-negative cells (Tran et al, 2009). We also identified
CCL20 as the third-ranked gene. The receptor of CCL20, CCR6,
regulates the migration of Tregs (Yamazaki et al, 2008).
Though CCL20 was not expressed in murine Tregs, it was
significantly upregulated in activated human Tregs but not in
Teffs (Figure 2B). Another gene, ID3 (inhibitor of DNAbinding 3),
was ranked as the fifth key gene in our work. Id3-deficient
mice develop many autoimmune disease symptoms found in
primary Sjogren’s syndrome patients (Li et al, 2004). Single-
nucleotide polymorphisms in the neutrophil cytosolic factor 2
(NCF2) gene, the ninth-ranked hub, have been associated
with systematic lupus erythematosus in a Chinese population
(Yu et al, 2011).
In addition to hub genes already known to be important for
Treg function or autoimmune diseases or disorders (e.g., ID3),
a number of new key hub genes were identified that had so far
not been reported to play a role in regulating Treg function.
One of them was the plasminogen activator urokinase (PLAU)
gene, ranked as the fourth hub gene in our constructed
correlation network of Tregs. PLAU is a serine protease that
catalyzes the conversion of plasminogen to plasmin. Two
crucial regions have been defined: the N-terminal domain,
which binds the receptor, and the C-terminal domain, which is
endowed with catalytic activity (Mondino and Blasi, 2004).
PLAU activates plasminogen into plasmin, which in turn
degrades fibrin and prevents its extracellular deposition. This
process might be dysregulated in several disease processes
involving inflammation and tissue repair. Selective abrogation
of the murine Plau-Plau-receptor interaction in vivo reveals a
role for these proteins in the suppression of fibrin-associated
inflammation (Connolly et al, 2010). Besides the role of PLAU
in fibrinolysis, it is required for murine T lymphocyte
proliferation and activation when T cells are studied as a
whole population (Gyetko et al, 1999). Although the results
from the whole T-cell population showed that PLAU might be
required for T lymphocyte activation, it is not clear whether
PLAU is involved in activation and suppressor function of
Tregs, the specific subpopulation of CD4þ T cells. This is not
only because the phenotype of this tiny subpopulation cannot
be easily represented by the whole T lymphocytes but also
because Tregs and conventional T cells (or effective T cells)
play a completely opposite role and might function through
different pathways.
Higher expression of PLAU in stimulated Tregs
To investigate the function of PLAU in Tregs, we first
characterized the kinetics of PLAU mRNA and protein
expression by measuring the time course of expression of
PLAU in both Tregs and Teffs following stimulation. The results
Table I Top 10 ranked hub genes identified in the constructed correlation network specific for human Tregs versus Teffs.
Gene
symbol Gene title N1 N2 Pf
Abs
(log10(Pf))
Abs
(log2(Pe))
Abs(log10(Pf))
þAbs(log2(Pe)) Comments
LRRC32 Leucine-rich repeat containing
32
21 152 3.7E 07 6.43 7.81 14.2 Known to be important for Treg
function (Probst-Kepper et al, 2009;
Wang et al, 2009)
IL1R1 Interleukin 1 receptor, type I 10 45 1.69E 06 5.77 7.12 12.9 Known to be important for Treg
function (Tran et al, 2009)
CCL20 Chemokine (C-C motif) ligand
20
27 348 0.000742 3.13 7.96 11.1 Its receptor CCR6 to be involved in
migration of Tregs (Yamazaki et al,
2008)
PLAU Plasminogen activator,
urokinase
21 127 1.38E 08 7.86 2.51 10.4 Verified in this work
ID3 Inhibitor of DNA binding 3,
dominant-negative helix-loop-
helix protein
16 127 2.14E 05 4.67 5.44 10.1 Id3-deficient mice with symptoms
found in primary Sjogren’s syndrome
patients (Li et al, 2004)
SLC35F3 Solute carrier family 35,
member F3
37 407 3.74E 06 5.43 3.54 8.97 Unknown
IL1R2 Interleukin 1 receptor, type II 27 307 9.75E 05 4.01 4.81 8.82 See IL1R1
FAM13A1 Family with sequence similarity
13, member A1
28 274 4.64E 06 5.33 2.99 8.33 Results not shown here
NCF2 Neutrophil cytosolic factor 2
(65 kDa, chronic granulomatous
disease, autosomal 2)
18 180 0.000194 3.71 4.42 8.13 Associated with systematic lupus
erythematosus (Yu et al, 2011)
C16orf67 Chromosome 16 open reading
frame 67
33 371 1.72E 05 4.76 3.24 8.01 Unknown
Note: N1, the number of literature-reported potential Treg-relevant genes with a correlation linkage to the corresponding gene in the Treg-specific correlation network;
N2, the number of genes with a correlation linkage to the corresponding gene; Pf, the P-value indicating potential functional relevance of the corresponding gene (refer
to Materials and Methods); Pe, the expression difference (refer to Materials and methods).
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show that PLAUmRNA expression was at a very low level in
unstimulated Tregs and Teffs (Figure 3A). Following activa-
tion by anti-CD3/-CD28/IL2, the expression of PLAU mRNA
was sharply upregulated in Tregs (Figure 3A). The expres-
sion of PLAU was also slightly upregulated in Teffs upon
activation, but its expression level was significantly lower
than in Tregs (Figure 3A). Such expression differences of
PLAU between Tregs and Teffs were significant, but not as
large as those of GARP or IL1R1 (refer to expression
difference values in Table I, Figure 2B, and Supplementary
Figure S13). Thus, PLAU might be overlooked by only
checking expression differences. The dynamics of PLAU
protein expression were measured by flow cytometry (FACS)
using a PLAU-specific antibody (see Materials and methods).
As shown in Figure 3B, similar to the mRNA, PLAU protein
expression was higher in Tregs compared to Teffs within the
first 6 h. We further monitored the protein expression of
PLAU for up to 12 days (Figure 3C) following stimulation by
EBV-B cells daily treated with IL2 (Probst-Kepper et al, 2009).
Our results show that the protein level of PLAU in Tregs was
approximately two times higher than in Teffs at different time
points during the first 7 days (Figure 3C). PLAU expression
declined afterB12 days following activation (Figure 3C). We
also show that the percentage of FOXP3high Treg cells was
495% at different measuring time, indicating a high purity
of Tregs even after several rounds of expansion (Figure 3D).
We further assessed whether PLAU was co-expressed with
FOXP3. By co-staining for PLAU and FOXP3, we observed
that PLAU was mainly expressed in FOXP3high Tregs
following stimulation (Figure 3D). These expression data
indicate that PLAU might play an important role in Treg
activity.
PLAU regulates FOXP3 and other important Treg
genes
To further evaluate whether PLAU is involved in the regulation
of FOXP3 expression, we assessed the regulatory effects of
PLAU on FOXP3 by using small interfering RNA (siRNA)
technology to knockdown PLAU. Our results show that a
knockdown of PLAU significantly downregulated FOXP3
protein expression compared to a control treated with non-
specific siRNA (si_NS) (Figures 4A and B). We observed a
2-day delay of FOXP3 protein downregulation compared to a
decrease in PLAU protein expression. We further detected a
significantly lower FOXP3 mRNA level in si_PLAU Tregs
compared to control Tregs transfected with si_NS
(Figure 4C). Our additional analyses show that 499.5% of
the gated analyzed Tregs were DAPI-negative living cells
at day 3 post siRNA transfection (Supplementary Figure S4).
Together, these results demonstrate that PLAU is critical for
regulating expression of FOXP3 in activated Tregs.
To test whether PLAU is also involved in controlling the
expression of other genes reported to be involved in or
potentially important to Treg suppressor function, we mea-
sured the transcription levels of 11 specific genes (e.g., EOS,
CTLA4, and LGMN; Supplementary Table 8). The measure-
ments were performed on each of the first 3 days post siRNA
treatment. A zinc-finger transcription factor of the Ikaros
family, Eos mediates Foxp3-dependent gene silencing in
murine Tregs by directly interacting with Foxp3 (Pan et al,
2009). Notably, our results show that knockdown of PLAU
caused a significant downregulation of EOS starting from day 1
post siRNA transfection (only shown on day 3, Figure 4C). The
gene coding for cytotoxic T-lymphocyte antigen 4 (CTLA4)
Figure 3 PLAU is highly expressed in Tregs. (A) mRNA expression of PLAU assessed by HTR time-series microarray in the first 6 h following anti-CD28/-CD3/IL2
stimulation. (B) Single staining of surface expression of PLAU assessed by FACS for the first day. For the first 6 h, the cells were restimulated by anti-CD28/-CD3/IL2, but
for the rest of the sampling time, the cells were independently restimulated by EBV-B cells daily treated with IL2. ‘Max’, maximum. (C) Single staining of surface
expression of PLAU assessed by FACS at time points from day 3 to day 12. (D) Coexpression of PLAU and FOXP3 assessed by FACS on day 3 and day 7 following
EBV-B cell restimulation. Enlarged red numbers indicate the overall percentage of the two right quadrants (i.e., FOXP3þ cells). Data represent three independent
experiments.
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might be involved in a centralmechanism throughwhich Tregs
control the function of antigen-presenting cells by binding
with CD80 and/or CD86 (Wing and Sakaguchi, 2010). We
observed a significant downregulation of CTLA4 in the PLAU-
knockdown Tregs on day 3 (Figure 4C). Another example of a
gene important for Treg function is the endosomal cysteine
protease legumain (LGMN) gene, which is significantly
upregulated in Tregs relative to Teffs and potentially induces
a partial Treg signature (Probst-Kepper et al, 2009). Similarly
to EOS and CTLA4, the mRNA level of LGMNwas significantly
decreased on day 2 after the knockdown of PLAU in Tregs
(Figure 4C). These results illustrate that the expression of a
number of key genes involved in Treg-suppressive function is
under the control of PLAU activity.
PLAU expression is positively correlated with Treg
suppressor function but inversely with cytokine
expression
To obtain further insight into the role of PLAU in Treg function,
we sorted Tregs into two subpopulations, PLAUlow and
PLAUhigh Tregs, according to the expression level of PLAU
protein by FACS (Figures 5A and B). To eliminate a potential
inhibitory effect of the PLAU antibody on PLAU function in
Tregs and to obtain more cells for further analyses, we
expanded the FACS-sorted PLAUlow and PLAUhigh Tregs by
re-stimulating them for at least four rounds. By co-culturing
either PLAUlow or PLAUhigh Tregs with Teffs, we observed that
PLAUhigh Tregs had a significantly greater potency in suppres-
sing Teffs’ proliferation relative to PLAUlow Tregs as demon-
strated by both H3 thymidine uptake experiments (Figure 5C)
and CFSE dilution measurement of Teffs (Figure 5E).
To further check whether low levels of PLAU expression
relative to PLAUhigh Tregs have a similar effect compared to the
knockdown of PLAU in Tregs versus control, we measured the
expression level of the 11 genes as described for the siRNA
experiments. As expected, the protein expression of PLAU and
FOXP3was significantly higher in PLAUhigh Tregs compared to
PLAUlow Tregs in the expanded Treg set (Figure 5D). We
observed significantly highermRNAexpression for 6 out of the
11 genes in PLAUhigh versus PLAUlow Tregs. These include
genes, for example, FOXP3, PLAU, GARP, CTLA4, and EOS
(Figure 5F). We also observed a higher protein expression of
GARP in PLAUhigh Tregs (Figure 5D). In addition, we found a
significantly higher mRNA level of LGMN in PLAUhigh Tregs
(Figure 5F). These results not only further confirm a key role of
PLAU in Treg function, similar to the data obtained from siRNA
experiments, but also show a correlation between the
expression of some known key genes and the suppressive
activity of Tregs. Our results also show that PLAU is a stable
surface marker for selecting human Tregs with higher
suppressive potency.
We further studied the mRNA expression of a number of
cytokines and related genes in PLAUhigh Tregs compared to
PLAUlow Tregs using real-time PCR array. A total of 84 genes
related to the three classes of CD4þ Tcells (Th1, Th2, and Th3)
were analyzed. An inverse relationshipwas found between the
level of PLAU in Tregs and the expression of cytokines
normally repressed in Tregs. In all, 9 out of the 84 genes were
significantly downregulated in PLAUhigh Tregs (Figure 5G)
though no cytokine genes were repeatedly observed to be
significantly upregulated. For instance, the Th2 cytokine genes
Figure 4 Knockdown of PLAU downregulates FOXP3 and other known
important Treg genes. (A) Knockdown of PLAU by electroporation-mediated
siRNA assessed by FACS. Before performing the knockdown experiments, we
first restimulated the Tregs by co-culturing them with EBV-B cells for 3 days. To
remove the B cells, we collected CD4þ cells by FACS before the knockdown
experiments. The Tregs were rested for another 3 days after siRNA transfection
and were then analyzed by FACS. (B) Left, the gated Tregs, PLAU expression
assessed by FACS; right, the gated Tregs, expression of FOXP3 protein
assessed by FACS. Enlarged numbers indicate the geometric mean of
fluorescence intensity of the corresponding protein. ‘Max’, maximum. (C)
Downregulation of mRNA levels of PLAU, FOXP3, EOS, CTLA4, and LGMN
assessed by real-time qPCR analysis. The numbers on the y axis indicate fold
change relative to RPS9 (Bruder et al, 2004). The percentage under each
subfigure represents the decreased percentage of the corresponding gene in
Tregs transfected with specific siRNA against PLAU (si_PLAU) compared to
Tregs transfected with non-silencing siRNA (si_NS). Error bars represent
standard deviation (s.d.) values. The P-values indicate the results from a one-
tailed Student’s t-test for three repeated measurements. Pp0.05 is indicated by
*Pp0.01, by **Pp0.001, and by *** for all the figures. The qPCR results
displayed here were from experiments performed on day 3 post siRNA
transfection for all the genes, except for LGMN on day 2 post siRNA. Data
represent two to four independent experiments.
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IL5 and IL13 and the Th1 cytokine colony-stimulating factor 2
(CSF2) gene were significantly upregulated in PLAUlow Tregs,
while other important Treg genes were downregulated
(Figures 5G and F). The genes CSF2, IL5, and IL13
(Figure 5H) are located in the same cluster on chromosome
region 5q31 (Le Beau et al, 1993) and therefore might be
directly or indirectly coregulated by PLAU.
We also observed a significant downregulation of interferon
regulatory factor 4 (IRF4) and IL15 in PLAUhigh Tregs
(Figure 5G). IRF4 promotes Th2 cytokine production in
CD4þ Teffs (Honma et al, 2008), while IL15 induces type 1
and type 2 CD4þ T-cell proliferation (Niedbala et al, 2002).
The expression of murine Irf4 in Tregs might depend on Foxp3
and regulate Th2 differentiation (Zheng et al, 2009). The
complexity of these regulations might be worthy of further
investigation. The costimulator of antigen-specific CD4þ
T cells (Niedbala et al, 2002) TNFRSF9, also known as
CD137 or 4-1BB, was significantly decreased in PLAUhigh
Tregs. Similarly, the expression of TNFRSF8 (CD30), which is
involved in NF-kB activation (Aizawa et al, 1997), was also
reduced in PLAUhigh Tregs. The results about cytokines and
key Treg genes indicate that the low level of PLAU in PLAUlow
Tregs could be responsible for the high expression of Treg-
mediated cytokines andmake PLAUlow Tregsmore reminiscent
of the molecular characteristics of Teffs.
PLAU mediates Treg suppressor function via
STAT5 and ERK signaling pathways
To investigate the mechanisms through which PLAU mediates
Treg suppressor function, we studied the two defined domains
of the PLAU protein, that is, the N-terminal domain binding the
receptor as well as the C-terminal domain with catalytic
activity (Mondino and Blasi, 2004). We first examined the
catalytic domain using a specific inhibitory antibody. Interest-
ingly, the suppressive capability of Tregs pretreated with the
catalytic inhibitor was significantly impaired as shown by
CFSE dilution measurement of co-cultured Teffs (Figure 6A)
while the control IgG did not show significant effects
(Supplementary Figure S5). In order to identify the signaling
pathways through which the PLAU catalytic domain mediates
Treg suppressor function, we assessed STAT1, STAT3, STAT5,
ERK1/2, AKT, and JNK1/2 as potential PLAU targeted
signaling pathways suggested by the molecular pathway
databases (Nikitin et al, 2003) or by the literature (Murawski
et al, 2006). Following stimulation of Tregs by anti-CD3/-
CD28/IL2, we did not observe any significant difference in the
phosphorylation of STAT3, AKT, and JNK1/2 in the presence or
absence of the catalytic inhibitory antibody (Figure 6F).
Moreover, we could not observe apparent STAT1 phosphoryla-
tion in the first 90min of stimulation either in the presence
or in the absence of the catalytic inhibitory antibody
(Supplementary Figure S6). However, Tregs pretreated with
the catalytic inhibitory antibody showed much less phosphor-
ylation of STAT5 and ERK1/2 protein comparedwith untreated
control Tregs (Figures 6D and E). It has been described that
activation of STAT5 is required for upregulation of FOXP3
expression in both human and murine Tregs (Murawski et al,
2006) and that human Tregs display a greater capacity to
phosphorylate ERK compared with Teffs upon TCR-mediated
activation (Crellin et al, 2007). We therefore conclude that
PLAU mediates Treg suppressor function via STAT5 and ERK
signaling pathways.
We next examined whether the receptor-binding domain of
PLAU plays a role in controlling the suppressor function of
Tregs toward Teffs. To evaluate whether PLAU protein can
directly affect the proliferation of Teffs via binding to the PLAU
receptor (PLAUR), which is highly expressed on human Teffs
but at a very low level on Tregs (Supplementary Figure S7), we
introduced purified high-molecular weight human PLAU
protein, known to have specific PLAUR binding capability,
into the culture media of Teffs. Addition of human exogenous
PLAU protein has only slight suppressive effects on the
proliferation of Teffs even at very high non-physiological
concentrations (B300 IU/ml, Figure 6B). Nevertheless, only a
very low level (o0.1 IU/ml, for ng and IU conversion see
Supplementary Figure S8) of secreted PLAU has been detected
in the supernatant of both stimulated Treg and Teffs,
respectively (Figure 6C). Since PLAU protein can only slightly
affect the proliferation of Teffs, based on the minor effect, a
partial blockage of PLAUR by the PLAUR antibodies is not
expected to significantly change this minor effect. Indeed, a
pretreatment with or without the PLAUR inhibitor did not
show a significant difference on the proliferation of Teffs.
Although the secreted level of PLAU is very low, the expression
level of the membrane-bound PLAU of activated Tregs is quite
high, raising an alternative possibility that the membrane-
bound PLAU might bind to the PLAUR on Teffs and
subsequently affect the proliferation of Teffs. Therefore, we
investigated the alternative possibility by asking whether a
blockage of PLAURon Teffs, before a co-culturewith Tregs, can
alter the suppressive capability of Tregs toward Teffs. The
results did not demonstrate a significant effect of the blockage
(Supplementary Figure S9). This rules out the possibility that
membrane-bound PLAU on Tregs promotes the suppressive
function of Tregs via binding to PLAUR on Teffs. We therefore
conclude that PLAU mediates the Treg suppressor function
intracellularly rather than via binding to PLAUR on Teffs
(Figure 6G).
Elevated Treg development but impaired
suppressor function of Cd44highCd62Llow Tregs in
Plau-KO mice
The critical role of PLAU in human Tregs motivated us to
further study its role in the murine Treg system. To investigate
whether murine Plau is involved in the development and
suppressor function of Tregs, we analyzed Plau-knockout
(Plau-KO) mice (Carmeliet et al, 1994). For this purpose, we
compared Plau heterozygous and/or homozygous knockout
(Plauþ / and/or Plau / ) mice with age- and sex-matched,
wild-type (WT) mice. Unexpectedly, in 3-week-old Plauþ / -
mice we observed a significantly higher frequency of Cd25þ
Foxp3þ cells among total Cd4þ single positive (SP) T cells in
the thymus compared to WT mice (Figure 7C). Further
analysis shows that almost all Cd4þCd25þFoxp3þ cells were
Cd4þ SP cells in the thymus and the frequency of Cd25þ
Foxp3þ cells among Cd4þ SP T cells in the thymus was
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significantly higher in Plauþ /- mice than in WT mice (Figures
7A–C). We further analyzed older mice, aged 10 and 12 weeks
and found there was no significant difference in the frequency
of Cd25þFoxp3þ cells among total Cd4þ Tcells of thymocytes
between KO mice and WT mice (Figure 7D). This might be
caused by thymic involution as the number of total thymocytes
in KO mice was sharply diminished in these older mice versus
3-week-old mice while WT mice had only a mild decrease
(Supplementary Figure S10). We have also checked spleno-
cytes in 10-week-old mice and found that the frequency
of Cd25þFoxp3þ cells among Cd4þ splenocytes in both
Plauþ / and Plau / mice was significantly higher than in
WT mice (Figure 7D). These results of enhanced Treg
development in Plau-KO mice are concomitant with the
observation that sustained expression of a serine protease
inhibitor can increase the population of Tregs in a specific
mouse strain (Subramanian et al, 2011).
We further studied the suppressive capability of peripheral
Tregs in Plau-KO mice and WT mice. Interestingly, our results
show that the Tregs from spleens in 20-week-old WTmice had
a significantly higher suppressor potential than Plau / mice
as demonstrated by both CFSE dilution and H3 thymidine
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uptake measurement (Figure 7E). But the Tregs isolated from
3-week-old Plau / or WT mice splenocytes had no
significant difference in suppressor potential (Supplementary
Figure S11). We further addressed the bases of the difference
between relatively younger and older mice. By co-staining
Cd44, Cd62L, Cd25, and Cd4, we have found that the
Cd44highCd62Llow Tregs in secondary lymphoid organs were
present at significant higher percentages in older mice than in
3-week-oldmice regardless ofWTor Plau-KOmice (Figure 7F).
This observation triggered us to check whether there were
differences in the suppressive function between two Tregs
subsets Cd44highCd62Llow and Cd44lowCd62Lhigh Tregs in Plau-
KO and WT mice. As indicated by both division percentages
and division numbers of CFSE dilution peaks, we have found
that the isolated Cd44highCd62LlowCd4þCd25þT cells in
littermate control WT mice had a significantly higher
suppressor potential than Plau / mice independent of
whether they are younger (5 weeks old) or older (10 weeks
old) as shown in Figure 7G. In contrast, no significant
difference was observed in the suppressor capabilities of
another Treg subset Cd44lowCd62Lhigh Tregs between litter-
mate WT and Plau / mice (Supplementary Figure S12).
Therefore, the high percentage of Cd44highCd62Llow Tregs
among the total Tregs in older mice contributes to the
phenotypic differences of the total Tregs between WT and
Plau / mice. The effects of Plau on total Tregs in relatively
older mice coincide very well with that in cultured human
Tregs. This is due to the fact that the major fraction of Tregs in
older mice are Cd44highCd62Llow Tregs. These cells are
‘memory-like’ Tregs while almost all the cultured human
Tregs are CD45ROþ memory Tregs after several-round
exposures to EBV-B cells. In summary, these data suggest that
Plau expression impaired the development of Cd4þCd25þ
Foxp3þ Tregs in murine thymus while it was critical for
promoting Cd44highCd62Llow Treg suppressor function.
Discussion
In this work, we identified PLAU as a novel key gene for Treg
suppressor function from an undirected correlation network
instead of a transcription regulatory network of Tregs. The
high predictive power of this network strategy is a result of the
utilization of the queen bee-surrounding principle described
here.
The proposed strategy is especially powerful in identifying
key Treg genes which are not among the most significantly
differentially expressed genes, but are still significantly
differentially expressed between Tregs and Teffs. As shown in
Table I, PLAU did not show a very-high expression difference
between Tregs and Teffs compared to the other top hubs. PLAU
has already been reported to be involved in fibrinolysis, tumor
metastasis (Ulisse et al, 2009), neurodegenerative (Finckh et al,
2003), and other diseases (reviewed in Mondino and Blasi,
2004). However in this work, we showed a new function of
PLAU, namely, an important role in human and murine Treg
suppressor function. Therefore, PLAU might be important for
autoimmunity. It has already been reported that murine Plau is
required for T lymphocyte activation and proliferation when
Tcells were studied as a whole population (Gyetko et al, 1999).
Our results however show that the expression level of PLAU
was inversely correlated with the expression level of Th1 and
Th2 cytokines and CD4þ activation markers in human Tregs.
This might demonstrate a dual role of PLAU in human Teffs and
Tregs. PLAUmight be a mitogen (Cohen et al, 1981) for human
Teffs and activator of cytokine expression of Teffs but act as an
inhibitor of cytokine expression for Tregs. This dual role might
be caused by Treg-specific genes and/or pathways. Treg-
repressed cytokine expression was already reported to be
repressed by FOXP3, EOS, and/or other important genes in
Tregs.
Moreover, we assessed the regulatory effects of PLAU by
siRNA-knockdown experiments, antibody inhibitory experi-
ments, and FACS-sorted cellular experiments in human Tregs.
These experiments have not only demonstrated the impor-
tance of PLAU in the expression regulation of key Treg genes,
but also shown the critical role of PLAU in Treg suppressor
function. Furthermore, our results from murine experiments
have revealed that Plau expression decreases murine thymic
Foxp3þ Treg development while promoting Cd44highCd62Llow
but not Cd44lowCd62Lhigh Treg suppressor function. Our
further investigation shows that PLAU mediates Treg suppres-
sor function via STAT5 and ERK signaling pathways. The data
presented here conclusively demonstrate that PLAU is
Figure 5 PLAUhigh Tregs exhibit higher potential in suppressing effector T cells and express higher levels of Treg-important genes, but they express lower levels of
cytokine genes compared to PLAUlow Tregs. (A) PLAUhigh and PLAUlow Tregs were sorted by PLAU expression level (left, isotype control; the figure in the right column is
divided into three parts: negative, low, and high levels of PLAU expression). (B) FACS of the PLAUhigh (red line) and PLAUlow Tregs (black line) immediately after sorting.
(C) The suppression assay of different cells populations assessed by uptake of [H3]thymidine (H3-TdR) (refer to Materials and methods). Error bars represent s.d. values.
Results are representative of three independent experiments. (D) Higher expression of PLAU, FOXP3, and GARP in PLAUhigh than PLAUlow Tregs assessed by FACS at
day 3 post restimulation. The PLAU subsets of Tregs were expanded for at least four rounds. Of note, in this panel EBV-B cells were not sorted out before FACS analysis.
Results are representative of three independent experiments. (E) The CFSE dilution measurement of the Teff proliferation co-cultured with Tregs at various ratios of
PLAU_high (upper row) or PLAU_low (lower row) Tregs to Teffs as well as co-cultured EBV-B cells after 4 days. Number in each histogram represents the percentage of
dividing cells from the total population (the total population indicates the gated DAPI-negative and CD4þ , CFSE stained Teffs). Results are representative of three
independent experiments. (F) Higher mRNA levels of FOXP3, GARP, LGMN, CTLA4, and EOS in PLAUhigh Tregs assessed by real-time qPCR analysis. The numbers
on the y axis indicate fold changes relative to RPS9. The numbers under each subfigure represent the increased fold changes in PLAUhigh Tregs compared to PLAUlow
Tregs. The qPCR analysis was performed after the removal of B cells by FACS before extracting RNA. The P-values represented by ‘*’ symbols indicate the results from
a one-tailed Student’s t-test for three replicates. Results are representative of three independent experiments. (G) PLAUlow Tregs reversed the expression of Treg-
repressed cytokines as assessed by a human Th1-Th2-Th3 cytokine PCR array. Left, numbers on the y axis indicate fold changes relative to actin. Data represent two
independent experiments. The reported genes are the overlap of the two independent experiments, which show at least 1.5-fold decrease in PLAUhigh versus PLAUlow
Tregs. Right, Venn diagram of the two independent experiments. The numbers specify the number of genes that decreased at least 1.5-fold. (H) Independent real-time
PCR confirmed the expression of the Treg-repressed cytokines in (G), such as IL5, IL13, and CSF2. The percentage under each subfigure represents the decreased
percentage of the corresponding gene in PLAUhigh versus PLAUlow Tregs. Error bars represent s.d. values. The P-values represented by ‘*’ symbols indicate the results
from a one-tailed Student’s t-test for three replicates.
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important for the suppressive capability of Tregs. Thus, a new
component of regulation of Treg suppressor function was
discovered.
The construction of a dynamic correlation network of
human Tregs provides a valid starting point for researchers
who study human autoimmune diseases and/or Treg function.
A key value of this human Treg functional association network
is to provide subnetworks of other genes involved in the
suppressor function of Tregs, such as the subnetworks of
FOXP3 and GARP described here. Furthermore, since we
successfully predicted and validated a vital role for PLAU in
Treg suppressor function, the other top-ranked candidate hubs
predicted from this work might also be very relevant. The
proposed strategy for the identification of PLAU is generally
applicable in discovering key candidate genes and the under-
lying networks associated with other human diseases.
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Materials and methods
Mice
B6.129S2-Plautm1mlg/Jmice have been described elsewhere (Carmeliet
et al, 1994) andwere purchased from the Jackson Laboratory. All of the
WT, Plauþ / , and Plau / mice used were siblings from breeding
pairs between heterozygous Plauþ / mice. All mice were kept and
bred in specific pathogen-free conditions at the Animal Facility at
Helmholtz Center for Infection Research in Braunschweig, Germany.
All animal experiments were in accordance with protocols approved
by the local authorities.
Isolation and cultivation of human Treg/Teff cells
Stable human alloantigen-specific Tregs and Teffs derived from
sorted CD4þCD25high and CD4þ CD25 peripheral blood T cells
were from the same batch of Tregs and Teffs from our recent work
(Probst-Kepper et al, 2009). Retroviral transduction, isolation, and
culture of human alloantigen-specific Teff cells with GARP coupled to
an IRES-driven GFP or empty control GFP has been described
(Probst-Kepper et al, 2009). IMDM (Gibco) supplemented with 10%
FCS (Gibco), 100U/ml penicillin, 100 mg/ml streptomycin (PAA) and
50 mM m-mercaptoethanol (Sigma-Aldrich) was used for cell culture.
Recombinant human IL2 (Proleukin, Novartis) was added daily to
Treg culturemedium at a concentration of 100U/ml, as we previously
described (Probst-Kepper et al, 2009) and in a similar way by others
(Stockis et al, 2009; Tran et al, 2009). All the Tregs/Teffs were stably
maintained and restimulated by EBV-B cells weekly as previously
described (Probst-Kepper et al, 2009). In addition, peripheral blood
CD4þCD25 Teffs (but not Tregs) freshly isolated using Invitrogen
Dynabeads human regulatory CD4þCD25þ T cell kits were
characterized in Supplementary Figure S13 and were used for
suppression assays. Informed consent was obtained before the blood
was taken.
Flow-cytometric analysis and antibodies
Human FOXP3 expression was detected with anti-FOXP3 mAbs after
fixation and permeabilization of cells by the protocol provided by the
manufacturer (206D, Biolegend). PLAU protein expression was
analyzed by surface staining with mAbs against human PLAU B-chain
(No. 394 or 3689, American Diagnostica) followed by a secondary
antibody PE Goat anti-mouse IgG (minimal cross-reactivity) (Biole-
gend). PE or PE-Cy5 rat anti-mouse Foxp3 (FJK16s, eBioscience), FITC
rat anti-mouse Cd4 (L3T4, BD), APC rat anti-mouse Cd25 (PC61, BD),
and pacific-blue rat anti-mouse Cd8 (53-6.7, eBioscience) were used to
analyze murine cell populations. Pacific-blue rat anti-mouse Cd4
(RM4-5, Biolegend), APC rat anti-mouse Cd25 (PC61, BD), PE-cy7
rat anti-mouse Cd44 (1M7, BD), and PE rat anti-mouse Cd62L
(MEL-14, eBioscience) were used to sort Cd44highCd62Llow and
Cd44lowCD62Lhigh Treg subsets. FACSCalibur (BD LSR II for murine
cells) was used for data acquisition, and the data were analyzed with
FlowJo software.
Cell sorting and suppression assay
To remove the EBV-B cells from human Tregs, we collected CD4þ cells
by FACS before the knockdown experiments. The cultured Tregs were
first stained with FITC-conjugated mAbs against CD4 (RPA-T4, BD)
and then sortedwith a BDAria II. To separate Tregswith different PLAU
expression levels, the Tregs were first restimulated for 3 days, stained
with PLAU, and then sorted by the BDAria II into two subpopulations:
PLAUlow and PLAUhigh Tregs. For the suppression assay of humanTregs
by [H3]thymidine incorporation, each of the different sets of Tregs was
co-cultured with Teffs (105) with different ratios, as well as EBV-B cells
(without IL2 addition). The human cells were cultured for 72 h in
96-well flat bottom plates and pulsed with [H3]thymidine (1 mCi/well,
Amersham, now Perkin-Elmer) for the last 6 h. For mouse Treg
suppression assays by [H3]thymidine incorporation, Cd4þCd25þ
Tregs and Cd4þCd25 Teffs were sorted by costaining Cd4-FITC
(RM4-5, BD) and Cd25-APC (PC61, BD) on murine splenocytes and
peripheral lymph nodes (LNs). Cd4þCd25þ Tregs sorted from WTor
Plauþ / or Plau / micewere co-cultured with 105WTCd4þCd25
Teffs at different ratios, together with WT irradiated splenocytes as
feeder cells and 1 mg/ml CD3e (BD). The isolated cells were co-cultured
in RPMI medium (Gibco) supplemented with 10% FCS (Gibco),
50U/ml penicillin/streptomycin, 25mM HEPES (Gibco) and 50 mM
b-mercaptoethanol (Invitrogen). The murine cells were cultured for
72 h in 96-well round bottom plates and pulsed with [H3]thymidine
(1 mCi/well) for the last 6 h. For the human CFSE dilution measure-
ment, each of the different sets of Tregs was co-cultured with CFSE-
labeled Teffs (105) with different ratios, as well as EBV-B cells (without
IL2 addition). The human cells were cultured for 4 or 5 days in 96-well
flat bottom plates and the gated DAPI (from Invitrogen) negative and
CD4þ , CFSE (from Invitrogen) stained Teffs were measured by FACS.
CFSE at a concentration of 1 mMwas used to label Teffs. For the murine
CFSE dilution measurement, different sets of Tregs (total Cd4þCd25þ
Tregs, or Cd44highCd62Llow or Cd44lowCD62Lhigh Treg subsets) and
Cd4þCd25- Teffs were sorted from murine splenocytes and peripheral
LNs. Different sets of Tregs sorted fromWTor Plau / mice were co-
cultured with 105 WT CFSE-labeled Cd4þCd25 Teffs at different
ratios, together with 4E5WT irradiated splenocytes as feeder cells and
1 mg/ml CD3e. All the feeder cells were depleted with total T cells by
total T-cell microbeads (CD90.2, Miltenyi Biotec) and were isolated
from relatively older mice (420 weeks) to ensure the maturation and
effectiveness of antigen-presenting cells (Dakic et al, 2004). The gated
DAPI-negative and CD4þ , CFSE stained murine Teffs were measured
by FACS after 3.5 day.
Figure 6 PLAU mediates Treg suppressor function via STAT5 and ERK signaling pathways. (A) The inhibition of the catalytic domain of the membrane-bound PLAU in
Tregs impaired Treg suppressor function. Left, the CFSE dilution measurement of the Teff proliferation at various ratios of Tregs to Teffs at day 4 after being co-cultured
with Tregs pretreated (upper row) or not (lower row) with the PLAU catalytic domain inhibitor as well as EBV-B cells. Number in each histogram represents the
percentage of dividing cells from the total population (the total population indicates the gated DAPI-negative and CD4þ , CFSE stained Teffs). Right, the upper figure is
the experimental scheme. The lower one is the suppression percentage converted from the CFSE results in the left column. The suppression percentage is converted by
comparing the proliferation percentage of Teffs at a given ratio to Tregs to the proliferation of stimulated Teffs alone without the presence of Tregs. (B) Adding exogenous
PLAU protein with the specific binding capability to the PLAUR into the culture media of Teffs has only very slight suppressive effects on the proliferation of Teffs at very
high doses. Left, the upper row is the CFSE measurement of the Teff proliferation at various concentrations of exogenous PLAU protein at day 4 after being co-cultured
with EBV-B cells. The lower row is the control one in the absence of exogenous PLAU protein but with the same concentration of buffer. Right, the upper figure is the
experimental scheme. The lower one is the suppression percentage converted from the CFSE results in the left column. Lines are a guide for the eye. (C) Very low level
of secreted PLAU in the supernatant of cultured Tregs or Teffs. The upper one is the measurement from the supernatant of cultured cells at day 2 after being stimulated
by anti-CD3/-CD28/IL2. The lower one is the measurement at day 6 after being re-stimulated by EBV-B cells. Error bars represent s.d. values. (D) Impaired STAT5
phosphorylation assessed by FACS in Tregs at different time points following the anti-CD3/-CD28/IL2 stimulation in the presence of the PLAU catalytic domain inhibitor.
Only gated viable Tregs were displayed for all the phosphorylation results. Right, geometric (geo) mean fluorescence intensity of Tregs converted from the left column.
Max, maximum. Lines are a guide for the eye. (E) Impaired ERK1/2 phosphorylation assessed by FACS in Tregs at different time points following the anti-CD3/-CD28/IL2
stimulation in the presence of the PLAU catalytic domain inhibitor. Right, geometric (geo) mean fluorescence intensity of Tregs converted from the left column.
(F) Unaffected AKT, STAT3, and JNK1/2 phosphorylation assessed by FACS in Tregs at different time points following the anti-CD3/CD28/IL2 stimulation in the
presence of the PLAU catalytic domain inhibitor. (G) Schematic diagram showing the mechanistic model through which PLAU mediates the suppressive function of
Tregs. The red dashed arrows are the new knowledge added by this work. Data are representative of 2 (C) or 4–5 independent experiments in (A, B, D, E, F).
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PLAU catalytic inhibitory, exogenous PLAU
protein, secreted PLAU and PLAUR blockage
experiments
For the human PLAU catalytic inhibitory experiments, Tregs were
prestained with the specific PLAU catalytic inhibitor (394OA, Amer-
ican Diagnostica) at a concentration of 100 mg/ml at room temperature
for 90min and then washed twice before a following experiment, such
as suppression assay or signaling pathway analysis. The normal
murine IgG control without azide was from BD. For the control
purpose of the experiments of introducing exogenous purified high-
molecular weight human PLAU (124, American Diagnostica), we used
the same concentration of blank buffer, which was used as the solvent
of the purified PLAU protein. Secreted PLAU in the supernatant of
cultured media was measured by ELISA kit following manufacture’s
protocols (894, IMUBIND ELISA kit, American Diagnostica). For the
measurement of the secreted PLAU at day 2 stimulated by anti-CD3/-
CD28/IL2, 1E5 Teffs or Tregs were seeded in 200 ml media of 96-well
plate; for the measurement at day 6 restimulated by EBV-B cells (with
IL2), 5E5 Teffs or Tregs were seeded in 1ml media of 24-well plate. For
the PLAUR blockage experiments, Teffs were prestained with the
specific PLAUR antibody (3936, American Diagnostica) at a concen-
tration of 40mg/ml at room temperature for 60min and then washed
twice before a following experiment.
Phosphorylation assessment by FACS
Following the human PLAU catalytic inhibitor prestaining, Tregs were
stimulated by anti-CD3/-CD28/IL2. Before stimulation at 371C, Tregs
were first premixed with anti-CD3/-CD28 beads at 41C for 20min.
Tregs were then sampled and fixed by BD cytofix buffer at various time
points. The monoclonal antibodies recognizing the specific phosphor-
ylation sites for Alex647 STAT1[pY701], PE STAT3[pY705], Alex647
STAT5[pY694], PE-Cy7 ERK1/2[pT202/pY204], and Alex647
AKT[pS473] were all BD Phosflow products. Rabbit mAB JNK1/
2[pT183/pY185] and its secondary antibody Alex647 goat anti-rabbit
IgG were from Invitrogen. The staining and measurement of the
phosphorylation of these proteins was performed using BD Phosflow
protocols.
siRNA knockdown
siRNA against human PLAU and non-silencing control siRNA were
obtained from Santa Cruz Biotechnology. One hundred picomoles of
siRNA was mixed with Tregs resuspended in 100ml human T cell
Nucleofector solution (Lonza Amaxa). The mixture was immediately
exposed to electroporation by the Nucleofector II device (Lonza
Amaxa) and placed in 371C prewarmed IMDM with 100U/ml IL2.
Before performing the knockdown experiments, we first restimulated
Tregs by co-culturing themwith EBV-B cells for 3 days. To remove the B
cells, we collected CD4þ cells by FACS before the knockdown
experiments. Before a further analysis, the Tregs were rested for
another 1 day, 2 days, or 3 days after siRNA transfection.
Real-time RT-PCR (qPCR) and pathway PCR array
RNA was isolated with the RNeasy Mini Kit (Qiagen) according to
manufacturer’s protocol and additionally purified by on-column
RNase-free DNase digestion (Qiagen). Purified and concentrated
RNA was then reverse-transcribed using Superscript III reverse
transcriptase (Invitrogen). qPCR was conducted on a LightCycler 480
(Roche) as previously described (Pfoertner et al, 2006). The following
primers were finally used in our qPCR analysis. FOXP3 forward (50–30)
ACC TAC GCC ACG CTC ATC; FOXP3 reverse (50–30) TCATTGAGTGTC
CGC TGC T; CTLA4 forward TGC AGC AGT TAG TTC GGG GTT GTT;
CTLA4 reverse CTG GCT CTG TTG GGG GCATTT TC; TGFB1 forward
CGC AAGGAC CTC GGC TGGAAGTGG; TGFB1 reverse GAG GCG CCC
GGG TTA TGC TGG TTG. The primers GARP forward GAT GGG GAA
ACT GAG GCT TAG GAA, GARP reverse ACC CCC AAT CTC ACC CCA
CAA ATA, LGMN forward CTC GCTCCAGGACCT TCT TCACAA, and
LGMN reverse GCT TCC TGC TCC TCA AAA CTA ACAwere from our
previous work (Probst-Kepper et al, 2009). We also used qPCR primers
from Qiagen for the genes RPS9, PLAU, IL1R1, S1PR1, IKZF4 (EOS),
GITR, LGALS3, CD127, IL13, CSF2, IL5, and IL2. RPS9 was used as an
internal standard (Bruder et al, 2004) in our qPCR analysis. Human
Th1-Th2-Th3 cytokine PCR array was employed to systematically
analyze the expression of cytokine gene representative of Th1, Th2,
and Th3 cells by the protocol provided by the manufacturer
(SABiosciences). Internal controls were included in the array, such
as b-actin (chosen here). PCR array analysis was followed by the
SABiosciences online tool.
Microarray sampling and RNA preparation
Human Tregs or Teffs were mixed with anti-CD3/anti-CD28-coated
Dynabeads (Invitrogen) at a ratio of 1:1 and with 100U/ml of IL2
(Proleukin, Novartis) and were distributed with 4106 cells into
1.5ml microtubes (Eppendorf) for each time point. Before the cells
were cultured at 371C, they were first stored at 41C to allow cells and
beads to settle properly. Samples were taken every 20min during the
first 6 h following stimulation, except for TeffGARP and TeffGFP cells,
which were measured at time points 0, 100, and 360min. The cells
were centrifuged, and the cell pellets were lysed in RLT buffer (Qiagen)
and immediately stored at  701C. RNAwas isolated with the RNeasy
Mini Kit (Qiagen) according to manufacturer’s protocol and addition-
ally purified by on-column RNase-free DNase digestion (Qiagen). RNA
quality was checked by RNA 6000 Nano assay (2100 Bioanalyzer,
Agilent). The comparability between stimulation results by anti-CD28/
anti-CD3 beads (IL2, 100U/ml) and EBV-B cells (IL2, 100U/ml) is
shown in Supplementary Figures S14 and S15.
Figure 7 Elevated thymic Foxp3þ Treg population while diminished suppressive capability of Cd44highCd66Llow Tregs in Plau-KO mice. (A) Percentages of Cd4þ SP
cells among murine thymocytes isolated from wild-type (WT) control mice and Plau heterozygous knockout mice (Plauþ / ) assessed by FACS. (B) Percentages of
Cd25þFoxp3þ cells among murine Cd4þ SP thymocytes isolated from WT and Plauþ / mice assessed by FACS. Only gated Cd4þ SP cells from (A) are shown in
(B). Data represent one of the four mice per group. (C) Comparison of percentages of Cd25þFoxp3þ cells among murine Cd4þ SP thymocytes between 3-week-old
WT and Plauþ / groups. Data are representative of two independent experiments. (D) Left, comparison of percentages of Cd25þFoxp3þ cells among murine total
Cd4þ thymocytes between WT and Plauþ / and/or Plau / groups, aged 12, 10 and 3 weeks. Error bars represent s.d. values. P-value represented by ‘*’ symbols
indicate results from a one-tailed Student’s t-test for n mice per group (the corresponding number n per group is indicated under each group column). Right, comparison
of percentages of Cd25þFoxp3þ cells among murine total Cd4þ splenocytes between WT, Plauþ / and Plau / groups in 10-week-old mice. (E) Comparison of
suppressive capability of Cd4þCd25þ Tregs between littermate WT, Plauþ / , and Plau / groups, age X20 weeks. Left, proliferation assessed by uptake of
[H3]thymidine. The P-value above each ratio represented by ‘*’ symbols indicates the results from a one-tailed Student’s t-test between WT and Plau / groups. Right,
proliferation assessed by the CFSE dilution measurement of Cd25 Ths co-cultured with Plau / or WT Tregs as well as irradiated feeder cells and Cd3 at various
ratios of Tregs to Teffs after 3.5 days. Number in each histogram represents percentage of dividing cells from the total population (the total population indicates the gated
DAPI-negative and CD4þ , CFSE stained Ths). (F) Left, the gating scheme used to analyze frequencies of Cd44highCd62Llow Tregs. Right, comparison of percentages of
Cd44highCd62Llow Tregs among total Tregs in spleen (SPL), peripheral LN (pLN) or mesenteric LN (mLN) from WT and Plauþ / and/or Plau / between groups of
mice aged 24 and 3 weeks. The P-value represented by ‘*’ symbols indicates the results from a one-tailed Student’s t-test. (G) Cd44highCd62Llow Tregs from Plau–/– mice
has significantly lower suppressive function than that from WT littermates. Left, proliferation assessed by the CFSE dilution measurement of Cd25 Ths co-cultured with
Cd44highCd62Llow Tregs from Plau / or WT mice aged 10 weeks as well as irradiated feeder cells and Cd3 at various ratios of Tregs to Teffs after 3.5 days. Right,
comparison of proliferation of Cd25 Ths co-cultured with Cd44highCd62Llow Tregs from littermate Plau / or WT mice aged 5 weeks as well as irradiated feeder cells
and Cd3 at various ratios of Tregs to Teffs after 3.5 days. Max, maximum. Data are representative of 3–5 independent experiments in (E, F, G).
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Microarray measurement and data preprocessing
For oligonucleotide microarray hybridization, 3mg RNA per sample
was labeled, fragmented, and hybridized to an Affymetrix HG-U133
plus 2.0 oligonucleotide array at the Array Facility of the Helmholtz
Centre for Infection Research. After the arrays were scanned, the
expression value for each gene was calculated by using Affymetrix
Microarray software 5.0 (MAS5). The average intensity difference
values were normalized across the sample set. Probe sets that were
absent in all the time-series samples, according to Affymetrix flags,
were removed. Probes with intensitieso50 at all the time points were
excluded. In this work, probes that were not changed42-fold among
any two different time points were also excluded. We further excluded
the probes with an average intensity ofo50 and the largest intensity
among different time points of o100. Probes were also excluded
corresponding to more than one Entrez gene ID based on the HG-U133
plus 2.0 array annotation file (http://www.affymetrix.com/, version
24, 7March 2008). Themicroarray sample at time point 120min of one
Treg time series was lost during operation, so we simply interpolated
the expression value for this time point by employing an intermediate
linear interpolation using the values at time points 100 and 140min.
Correlation network construction and analysis
Network construction
In this work, we demonstrated the identification of key genes by
constructing and analyzing a Treg-specific correlation network. We
constructed the correlation network by identifying correlation linkages
among pairs of genes. The correlation linkages were identified by
employing both the LC and the TCmethods. Both methods are capable
of discovering potential functional association between genes from
time-series data by considering positive/inverted correlation and time
shift. A significant correlationwith time shift between two genesmight
indicate a transcription regulatory relationship (Bar-Joseph et al,
2012). But to obtain accurate inference, we need much additional
information, a big portion of which are not available. We therefore
only simply considered the pairs with this type of correlation as
potential function-associated linkages in this work by not distinguish-
ing the specific type of detailed functional association (e.g., signal
transduction, transcription regulation or in the same pathways). The
LC method has been widely used to identify potential functional
association mainly based on a point-to-point comparison of gene
expression values from time-series data as recently reviewed (Bar-
Joseph et al, 2012). The TC method has also been demonstrated to be
useful in identifying potential functional association from time-series
data and to be complementary to the LC method based on extracting
main features of the change trend and the change level of gene
expression between consecutive time points (He and Zeng, 2006). Due
to different principles behind the LC and the TCmethods, we therefore
combined both methods to complement each other in order to identify
more complete potential functional associations between genes.
For this purpose, we calculated the LC score as defined by the LC
method (Qian et al, 2001), the maximal matched change trend (sc)
score and the correlation coefficient (cc) score for the maximal
matched change trend as defined by the TC method (He and Zeng,
2006) for each pair of genes in all the time-series data sets of Tregs and
Teffs. We then calculated PLC for the scores resulting from the LC
method as described (Qian et al, 2001). We also calculated PTC1 for the
TC method by extraction procedure I, as previously described (He and
Zeng, 2006). For the TC method, we here introduced another adapted
P-value (PTC2) calculation based on the reordered sc and cc distribution
curve (for details, see Supplementary Figure S16). Briefly speaking, the
reason to reorder the distribution table (curve) is that we found that
some of the pairs, which have a very high cc score but the sc score is
not very high, might still have a high chance to be potentially
functionally linked. So far, we obtained three different P-values (PTC1,
PTC2, and PLC) for each pair of genes in each replicate of the time-series
data set generated for a given cell type (Tregs or Teffs). In the following,
we set rules to extract Treg-specific correlation linkages. First, to
guarantee the reproducibility of the results, we restricted the
significantly correlated pairs to those repeatedly showing significant
P-values in both replicates of Tregs constantly by one of the three P-
values (PTC1, PTC2, and PLC). A standard P-value cutoff of 0.05, thewell-
established and extensively used threshold was applied. Second, in
order to obtain cumulative evidence generated in both replicates and
gained by both methods, we employed naive Bayesian integration
(combination) (Lu et al, 2005) by multiplying different P-values from
both replicates by the LC and the TC methods. This is based on the
assumption of the independency of the P-values generated by two
different methods due to the utilization of different principles and the
independency of the results from each replicate due to the difficulty in
obtaining synchronized T-cell stage before activation although all the T
cells were at the resting stage. Since both PTC1 and PTC2 were caused by
the TC method, we chose the minimal P-value generated by one of
them. Thus, only four P-values were eventually utilized for the
integration purpose. The cutoff for the integrated P-values was chosen
at 1e 9 based on a more stringent but also well-established P-value
threshold 0.01. The overall threshold 1e 9 was even stricter than the
product of the four individual P-values ((0.01)4¼1e 8) in order to
avoid the cases, such as those pairs with all the individual P-values
very close to the threshold of 0.01, which could be marginal.
We therefore set min (PTC1,Treg1*PTC1,Treg2, PTC2,Treg1* PTC2,Treg2)
*PLC,Treg1*PLC,Treg2p1e 9, where min() indicates the minimal value
of the two products of P values; Treg1/2 indicates the replicate of Treg 1
or 2. In the end, we only included the pairs satisfying both of the two
criteria for the reproducibility and the integrated evidence in Tregs but
the same pairs did not evenmeet the standards of the reproducibility in
Teffs, as Treg-specific correlation linkages. The strict criteria of the
reproducibility largely excluded those pairs with integrated P-values
slightly higher than the integrated P-value threshold in Tregs but
slightly lower than the integrated threshold in Teffs. Obviously, the
pairs that cannot satisfy the basic prerequisites of the reproducibility
(p0.05) has very less chance to pass the integrated P-value threshold
(based on 0.01). This has been demonstrated in Supplementary
Figure 17, where 499 and 95.5% of all the Treg-specific correlation
linkages show around 3- and 10-fold less P-values, respectively, in
average for each of the four individual P-values in Tregs than in Teffs.
For the remaining tiny proportion (o1%) of the correlation linkages,
they showed a very significant correlation only in one of the two
replicates of Teffs but had no significance in another one, which still
causes a very small final product of P-values integrated from replicates.
Apparently, we cannot consider this tiny fraction as significantly
correlated pairs in Teffs without consistent results between replicates.
Thus, all of linkages including the tiny fraction were Treg-specific
correlation interactions with high confidence.
Threshold robustness
In addition to being rational to choose the P-value thresholds, we have
also performed a robustness test in order to examine whether a
reasonable variation of the P-value thresholds will cause significant
changes in the resulted overall Treg-specific correlation network and in
the degree of predicted functional importance of some key candidate
genes. As shown in Supplementary Figure S18A, an order ofmagnitude
variation of thresholds [0.01, 0.1] around the reproducibility threshold
0.05 has generally obtainedo5% differences between the total number
of correlation linkages at various thresholds and those at the threshold
0.05. The maximum difference actually only 14.6% reduction of the
entire number of correlation linkages occurs at the case when changing
the threshold to 0.01. Particularly for the PLAU subnetwork, the same
threshold changes cause only very slight changes [6.82, 8.12] for the
logarithm ( log10) of Pf (see text), which indicates the degree of
potential functional importance (Supplementary Figure S18B). For
comparing purpose, it is worthy to notice that the  log10Pf value is
7.86 at the threshold 0.05 (Table I). For the GARP subnetwork, the
 log10Pf values have only fallen in a very narrow range [6.00, 7.12]
around 6.43 at the threshold 0.05 (Supplementary Figure S18D). All
these resulted  log10Pf values were still very significant and
consequently caused no change in the predicted high degree of
functional importance of these key candidate genes. The overlap
between the identified correlation linkages with PLAU (or GARP) at the
varied thresholds and those at 0.05 is also very high (X81%andX88%
for PLAU and GARP, respectively) (Supplementary Figures S18C and E).
We also changed the integrated P-value threshold around 1e 9 and a
Critical role of PLAU and Treg correlation network
F He et al
16 Molecular Systems Biology 2012 & 2012 EMBO and Macmillan Publishers Limited
similar observation has been obtained.We therefore concluded that our
strategy is quite insensitive to the choice of P-value thresholds.
Differential expression
We also defined the differential expression between Tregs and Teffs in
a combinatorial way. The expression difference over the measured
continuous time points between Tregs and Teffs was first evaluated by
two-tail paired Student’s t-test. Considering the difficulty in synchro-
nizing the cell state between the replicates of T cells, we generated t-
test P-values for all the possible pairs between the replicates of the two
cell types, namely, PtTreg1,Teff1, PtTreg1,Teff2, PtTreg2,Teff1, and PtTreg2,Teff2.
To guarantee the reproducibility of the expression difference between
the two cell types for all the replicates, we only chose genes with all
the four P-values ofp0.05. For those significantly increased genes in
Tregs versus Teffs, we required additional criteria as following. First,
we only chose genes with at least 50% of all the measured time points
(we here chose 9 out of 19 points) showing a Present/Marginal call in
both replicates of Tregs to obtain more benefits as suggested
(McClintick and Edenberg, 2006). Second, we only chose genes with
average intensityX50 in both replicates of the time-series data sets of
Tregs as low intensity will produce high variation (Amit et al, 2007;
Ambroise et al, 2011). Third, since t-test cannot distinguish which cell
type has a higher or lower expression, we only chose genes with
average intensity higher in both replicates of Tregs than both
replicates of Teffs by generating pair-wised comparisons as paired
for the t-test. For those significantly downregulated genes in Tregs, we
asked for the same three requirements for Teffs replacing Tregs as
stated above.
Key gene predictions
According to our network construction strategy (Figure 1E), we
calculated the functional P-value Pf for each gene using a cumulative
binomial distribution test. Furthermore, considering the non-synchro-
nization of the replicates of T cells, we calculated the average
expression difference by generating all the possible pairs between
the replicates of the two cell types, namely, mean(Treg1)/mean(Teff1),
mean(Treg1)/mean(Teff2), mean(Treg2)/mean(Teff1), and mean
(Treg2)/mean(Teff2), where mean() indicates the average intensity
of a given gene over time;Teff1/2 designates the replicate of Teff 1/2.
We then calculated the arithmetic mean (Pe) of the four pairs and
subsequently executed a log2 transformation of the mean (log2(Pe)) to
calculate average change fold for each gene between Tregs and Teffs as
a log2 transformation in general has better performance (Yang et al,
2002; Ambroise et al, 2011).
In order tomake the values of functional P-values (Pf) comparable to
the log2-transformed expression difference values, we performed a
log10 transformation on Pf. We then again used naive Bayesian
integration (Lee et al, 2004) by integrating the information of the
expression difference and the degree of potential functional impor-
tance of a given gene assuming both information is independent.
Following the rationale above, we used abs(log10(Pf))þ abs(log2(Pe))
as the integrated value to rank the potential importance of the
identified functional hub candidates. Furthermore, to avoid the cases
of the genes with very high expression difference but with no
significant Pf values or the cases of the genes with very significant Pf
values but no clear expression difference, we set up the following
prerequisite conditions to be matched before ranking: Pfp0.056 and
the corresponding gene was significantly downregulated or upregu-
lated (the upregulated ones are themain focus of this work), according
to our definition above. The only reason of choosing 0.056 rather than
the standard threshold 0.05 is to include FOXP3, the marginality of
which has been argued in the text. Of note, the upregulated or
downregulated hub genes were ranked separately.
Data availability
The complete time-series microarray data set (81 arrays) is
available in the Gene Expression Omnibus (GSE11292).
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